American Well Corporation

AMWL Healthcare Health Information Services

American Well Corporation’s revenue for fiscal 2025 (year ended December 2025) was $249.3 million, down 1.98% from fiscal 2024. In the quarter to June 2026, revenue fell 26.6%, EPS grew 52.4% and free cash flow grew 266.4%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years; insiders bought in the last twelve months.

11.68 0.70 −5.65%
Market cap
$210.6M
P/E
0.0×
Fwd P/E
−2.6×
Dividend yield
—
F-score
6/9
Altman Z
−7.95
Beneish M
−3.29
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Piotroski F-Score
5 6 6 6

+8 more TTM periods

ROE
(29.54%) (32.20%) (33.93%) (36.74%)
ROA
(21.82%) (23.58%) (25.19%) (26.93%)
ROIC
(135.53%) (95.94%) (100.51%) (115.53%)
Return on Tangible Assets
(45.00%) (50.09%) (55.10%) (61.34%)
Average Days of Receivables
87.87 87.79 72.75 76.54
Free Cash Flow per Share
(1.91) (2.69) (4.11) (3.98)
Free Cash Flow
(32.04) (44.63) (65.97) (64.46)
Capital Expenditures
(5.65) (2.80) (0.02) (2.42)
Other line items
Cash ROIC
(7.43%) (10.62%) (15.34%) (13.77%)
Accounts Receivable Turnover
4.12 3.68 4.10 3.66
Accounts Payable Turnover
38.77 28.59 34.95 17.87
Inventory Turnover
66.81 60.80 57.59 38.31
Average Days of Payables
5.89 4.53 5.17 17.26
Days of Inventory on Hand
3.35 3.75 3.72 5.28
Tax Rate
0.00 0.00 0.00 0.02
Research and Development Expense of Revenue
25.28% 26.60% 29.22% 29.32%
Selling, General and Administrative Expense of Revenue
48.99% 50.97% 52.67% 56.76%
Share Based Compensation of Revenue
5.95% 7.15% 8.83% 10.68%
Operating CF/Net income
0.34 0.48 0.69 0.55
Depreciation/Fixed assets
217.48 209.24 167.12 149.41
Capex/Depreciation
(0.16) (0.08) 0.00 (0.07)
Revenue per Share
13.04 14.31 15.54 16.35
Operating CF per Share
(1.57) (2.52) (4.11) (3.83)
Capex per Share
(0.34) (0.17) 0.00 (0.15)
Capex to Sales
0.03 0.01 0.00 0.01

Fold the line items

Columns are period end dates